峆一药业
(920478)
| 流通市值：7.45亿 | | | 总市值：12.25亿 |
| 流通股本：6700.42万 | | | 总股本：1.10亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 69,252,749.32 | 49,809,680.19 | 105,751,562.05 | 95,642,905.94 |
| 交易性金融资产 | 76,957,819.55 | 119,040,882.2 | 83,329,919.25 | 82,144,069.18 |
| 应收票据及应收账款 | 23,962,995.89 | 22,734,640.17 | 34,050,965.02 | 23,451,491.12 |
| 其中：应收票据 | 7,143,092.54 | 4,176,414.03 | 8,203,495.52 | 4,564,944.42 |
| 应收账款 | 16,819,903.35 | 18,558,226.14 | 25,847,469.5 | 18,886,546.7 |
| 应收款项融资 | 1,160,054.98 | 102,358.91 | 182,785.93 | 171,800 |
| 预付款项 | 1,250,574.18 | 3,399,234.44 | 1,173,876.49 | 5,838,185.59 |
| 其他应收款合计 | 1,546,025.61 | 3,250,494.54 | 2,805,062.86 | 3,629,055.91 |
| 存货 | 101,836,840.75 | 91,833,572.54 | 88,943,706.35 | 99,471,698.09 |
| 其他流动资产 | 22,829,402.58 | 21,446,528.69 | 18,377,447.74 | 16,175,065.76 |
| 流动资产合计 | 298,796,462.86 | 311,617,391.68 | 334,615,325.69 | 326,524,271.59 |
| 非流动资产: | | | | |
| 长期股权投资 | 221,689.46 | 71,384.06 | 71,384.06 | 330,000 |
| 固定资产 | 179,449,145.89 | 127,465,948.44 | 117,946,396.39 | 116,468,955.07 |
| 在建工程 | 118,754,676.37 | 172,307,363.66 | 144,387,265.97 | 129,536,297.04 |
| 使用权资产 | 242,552.93 | 524,191.52 | 805,830.13 | 1,136,807.94 |
| 无形资产 | 32,238,683.04 | 32,432,593.12 | 32,626,503.2 | 32,820,413.28 |
| 长期待摊费用 | 1,426,959.53 | 1,754,943.02 | 2,082,926.51 | 1,990,899.93 |
| 递延所得税资产 | 796,078.53 | 748,225.68 | 1,020,586.29 | 1,041,229.02 |
| 其他非流动资产 | 10,371,664.84 | 972,929.4 | 3,697,828 | 6,891,191.8 |
| 非流动资产合计 | 343,501,450.59 | 336,277,578.9 | 302,638,720.55 | 290,215,794.08 |
| 资产总计 | 642,297,913.45 | 647,894,970.58 | 637,254,046.24 | 616,740,065.67 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 48,292,603.63 | 46,299,049.07 | 53,857,850.13 | 42,440,995.17 |
| 其中：应付票据 | 8,610,656.43 | 12,728,762.25 | 10,710,172.45 | 12,264,634.63 |
| 应付账款 | 39,681,947.2 | 33,570,286.82 | 43,147,677.68 | 30,176,360.54 |
| 合同负债 | 922,579.88 | 57,505.84 | 1,171,974.26 | 2,205,105.2 |
| 应付职工薪酬 | 4,716,344.34 | 4,610,154.56 | 6,934,999.52 | 5,819,002.64 |
| 应交税费 | 632,791.75 | 3,935,128.66 | 5,252,378.94 | 6,840,821.38 |
| 其他应付款合计 | 5,930,301.14 | 6,354,421.63 | 6,870,001.93 | 8,355,992.47 |
| 一年内到期的非流动负债 | 306,938.62 | 531,032.02 | 788,464.28 | 1,177,118.99 |
| 其他流动负债 | 7,883.97 | 6,034.07 | 19,758.85 | 93,437.31 |
| 流动负债合计 | 60,809,443.33 | 61,793,325.85 | 74,895,427.91 | 66,932,473.16 |
| 非流动负债: | | | | |
| 长期借款 | 73,874,508.59 | 61,786,008.59 | 37,492,869.96 | 29,774,114.89 |
| 递延收益 | 690,754.43 | 723,929.43 | 757,104.43 | 790,279.43 |
| 递延所得税负债 | 22,446.03 | 31,491.11 | 12,381.51 | - |
| 非流动负债合计 | 74,587,709.05 | 62,541,429.13 | 38,262,355.9 | 30,564,394.32 |
| 负债合计 | 135,397,152.38 | 124,334,754.98 | 113,157,783.81 | 97,496,867.48 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 110,192,180 | 78,708,700 | 78,708,700 | 78,708,700 |
| 资本公积 | 68,494,435.85 | 99,595,280.79 | 99,212,645.73 | 98,192,285.58 |
| 减:库存股 | 2,342,795 | 2,342,795 | 2,342,795 | 4,685,590 |
| 盈余公积 | 27,475,212.41 | 27,475,212.41 | 27,475,212.41 | 23,423,090.5 |
| 未分配利润 | 300,874,398.72 | 315,846,856.37 | 315,211,053.38 | 315,044,592.39 |
| 归属于母公司股东权益合计 | 504,693,431.98 | 519,283,254.57 | 518,264,816.52 | 510,683,078.47 |
| 少数股东权益 | 2,207,329.09 | 4,276,961.03 | 5,831,445.91 | 8,560,119.72 |
| 股东权益合计 | 506,900,761.07 | 523,560,215.6 | 524,096,262.43 | 519,243,198.19 |
| 负债和股东权益合计 | 642,297,913.45 | 647,894,970.58 | 637,254,046.24 | 616,740,065.67 |
| 公告日期 | 2026-08-21 | 2026-04-28 | 2026-04-16 | 2025-10-28 |
| 审计意见(境内) | | | 标准无保留意见 | |